Objective: To study the effects of percutaneous etha- nol injection (PEI) in treatment of hepatocellular carcinoma (HCC). Methods: Blood samples were taken from 9 HCC pa- tients and detected by nested RT-PCR to find o...Objective: To study the effects of percutaneous etha- nol injection (PEI) in treatment of hepatocellular carcinoma (HCC). Methods: Blood samples were taken from 9 HCC pa- tients and detected by nested RT-PCR to find out AFPmRNA after PEI treatment 3-5 times within 2 weeks. Results: Three (44.44%) of 4 patients with AFPmR- NA positive turned to be negative after PEI treatment and 1 with AFPmRNA positive (11.11%) lasted within 2 weeks. Conclusion: PEI may diminish the possibility of dis- tant metastasis of HCC.展开更多
OBJECTIVES: To detect the expression of human alpha-fetoprotein mRNA (AFPmRNA) in peripheral blood (PBL) of recurrent hepatocellular carcinoma (HCC) by using nested reverse transcriptase polymerase chain reaction (nes...OBJECTIVES: To detect the expression of human alpha-fetoprotein mRNA (AFPmRNA) in peripheral blood (PBL) of recurrent hepatocellular carcinoma (HCC) by using nested reverse transcriptase polymerase chain reaction (nested RT-PCR) and to discuss relations between AFPmRNA and recurrent HCC. METHODS: Five ml peripheral blood samples were obtained from 19 patients with recurrent HCC. To identify HCC cells in PBL, liver-specific AFPmRNA was amplified from the total RNA extracted from the whole blood by nested RT-PCR. RESULTS: Seven patients (36.8%) with recurrent HCC were detected AFPmRNA, and 12 patients with recurrent HCC were AFPmRNA negative (63.2%). There was no significant relation between patients with AFPmRNA positive and AFPmRNA negative (P>0.05) in judging the origin of recurrent HCC. CONCLUSION: AFPmRNA may not be used as a marker of origin of recurrent HCC.展开更多
文摘Objective: To study the effects of percutaneous etha- nol injection (PEI) in treatment of hepatocellular carcinoma (HCC). Methods: Blood samples were taken from 9 HCC pa- tients and detected by nested RT-PCR to find out AFPmRNA after PEI treatment 3-5 times within 2 weeks. Results: Three (44.44%) of 4 patients with AFPmR- NA positive turned to be negative after PEI treatment and 1 with AFPmRNA positive (11.11%) lasted within 2 weeks. Conclusion: PEI may diminish the possibility of dis- tant metastasis of HCC.
基金This study was supported by a grant from the Research Foundation of the Army, China (No. Army Med 71).
文摘OBJECTIVES: To detect the expression of human alpha-fetoprotein mRNA (AFPmRNA) in peripheral blood (PBL) of recurrent hepatocellular carcinoma (HCC) by using nested reverse transcriptase polymerase chain reaction (nested RT-PCR) and to discuss relations between AFPmRNA and recurrent HCC. METHODS: Five ml peripheral blood samples were obtained from 19 patients with recurrent HCC. To identify HCC cells in PBL, liver-specific AFPmRNA was amplified from the total RNA extracted from the whole blood by nested RT-PCR. RESULTS: Seven patients (36.8%) with recurrent HCC were detected AFPmRNA, and 12 patients with recurrent HCC were AFPmRNA negative (63.2%). There was no significant relation between patients with AFPmRNA positive and AFPmRNA negative (P>0.05) in judging the origin of recurrent HCC. CONCLUSION: AFPmRNA may not be used as a marker of origin of recurrent HCC.